Peroxisome Proliferator Activated Receptor Ligands as Regulators of Airway Inflammation and Remodelling in Chronic Lung Disease
Inflammation is a major component in the pathology of chronic lung diseases, including asthma. Anti-inflammatory treatment with corticosteroids is not effective in all patients. Thus, new therapeutic options are required to control diverse cellular functions that are currently not optimally targ...
Main Authors: | Jane Elizabeth Ward, Xiahui Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2007-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2007/14983 |
Similar Items
-
Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γ Ligands in Lung Cancer
by: Raphael A. Nemenoff, et al.
Published: (2008-01-01) -
Studies on endogenous regulators and dietary ligands of peroxisome proliferator-activated receptors
by: Goto, Tsuyoshi
Published: (2011) -
Peroxisome Proliferator-Activated Receptors in Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2007-01-01) -
Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control
by: Jihan Youssef, et al.
Published: (2004-01-01) -
PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy
by: Chantal Donovan, et al.
Published: (2012-01-01)